A detailed history of Groupe La Francaise transactions in Eli Lilly & CO stock. As of the latest transaction made, Groupe La Francaise holds 184,581 shares of LLY stock, worth $189 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares
184,581
Previous 180,811 2.09%
Holding current value
$189 Million
Previous $141 Billion 1.64%
% of portfolio
1.88%
Previous 2.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$625.65 - $812.69 $2.36 Million - $3.06 Million
3,770 Added 2.09%
184,581 $139 Billion
Q2 2025

Aug 13, 2025

BUY
$713.71 - $898.95 $51.6 Million - $65 Million
72,332 Added 66.68%
180,811 $141 Billion
Q1 2025

May 14, 2025

SELL
$725.72 - $929.72 $2.1 Million - $2.7 Million
-2,900 Reduced 2.6%
108,479 $89 Billion
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $81 Million - $104 Million
111,379 New
111,379 $89 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Groupe La Francaise Portfolio

Follow Groupe La Francaise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupe La Francaise, based on Form 13F filings with the SEC.

News

Stay updated on Groupe La Francaise with notifications on news.